Gene therapy of hemophilia B
Kurachi, K.; Yao, S.N.
Thrombosis and Haemostasis 70(1): 193-197
1993
ISSN/ISBN: 0340-6245 PMID: 8236102 Document Number: 409531
Document emailed within 1 workday
Related Documents
Chao, H.; Walsh, C.E. 2004: AAV vectors for hemophilia B gene therapy Mount Sinai Journal of Medicine new York 71(5): 305-313Brdicka, R. 2001: Gene therapy of hemophilia--the next disappointment? Casopis lekaru ceskych 140(20): 640-641
Chuah, M.; Vandendriessche, T. 2007: Gene therapy for hemophilia "A" and "B": efficacy, safety and immune consequences Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 69(5-6): 315-334
Ill, C.R.; Yang, C.Q.; Bidlingmaier, S.M.; Gonzales, J.N.; Burns, D.S.; Bartholomew, R.M.; Scuderi, P. 1997: Optimization of the human factor VIII complementary DNA expression plasmid for gene therapy of hemophilia A Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 8 Suppl. 2: S23-S30
Jones, P. 1979: Organization of hemophilia therapy. the role of the hemophilia center Sangre 24(5-C): 998-1004
Lutze, G.; Schlote, A.; Beyer, H.; Kropf, S. 1985: Diagnosis of hemophilia and Willebrand-Jürgens syndrome. 2. Results of studies in hemophilia patients and hemophilia carriers Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 40(16): 479-483
Wulff, K.; Bykowska, K.; Lopaciuk, S.; Herrmann, F.H. 1999: Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene Acta Biochimica Polonica 46(3): 721-726
Vidal, F.; Farssac, E.; Altisent, C.; Puig, L.ís.; Gallardo, D. 2002: Implications of gene sequencing in the direct diagnosis of hemophilia by PCR-RFLP Haematologica 87(1): 109-110
Espinós, C.; Casaña, P.; Haya, S.; Cid, A.R.; Aznar, J.A. 2003: Molecular analyses in hemophilia B families: identification of six new mutations in the factor IX gene Haematologica 88(2): 235-236
Tong, X.W.; Engehausen, D.G.; Kaufman, R.H.; Agoulnik, I.; Contant, C.; Freund, C.T.; Oehler, M.K.; Kim, T.E.; Hasenburg, A.; Woo, S.L.; Kieback, D.G. 1998: Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy Anticancer Research 18(2a): 713-718
Chuansumrit, A.; Sasanakul, W.; Goodeve, A.; Treratvirapong, T.; Parinayok, R.; Pintadit, P.; Hathirat, P. 1999: Inversion of intron 22 of the factor VIIi gene in a girl with severe hemophilia a and Turner's syndrome Thrombosis and Haemostasis 82(4): 1379
Gécz, J.; Saksová, L.; Kádasi, L.; Véghová, E. 1992: Identification of a de novo mutation in a factor FVIII:C gene in a family requesting prenatal diagnosis of hemophilia a Bratislavske Lekarske Listy 93(9): 459-462
Seita, I.; Shinozawa, K.; Otaki, M.; Fujita, S.; Suzuki, T.; Amano, K.; Inaba, H.; Fukutake, K. 2009: Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B Rinsho Byori. Japanese Journal of Clinical Pathology 57(5): 417-424
Hilgartner, M.W. 1984: Complications of therapy in hemophilia Pediatrics 74(2): 290-291
Weinger, R.S.; Cimo, P.L. 1978: Home therapy for hemophilia Texas Medicine 74(6): 57-60
Hutaff, L.W. 1973: Specific therapy in hemophilia North Carolina Medical Journal 34(3): 193-196
Lillicrap, D.P.; Bridge, P.J.; Giles, A.R. 1990: Organization of a hemophilia genetic screening program. Ontario Hemophilia Study Group Progress in Clinical and Biological Research 324: 19-28
Poort, S.R.; Briët, E.; Bertina, R.M.; Reitsma, P.H. 1990: Two mutations of the factor IX gene including a donor splice consensus deletion and a point mutation in a Dutch patient with severe hemophilia B Thrombosis and Haemostasis 64(3): 379-384
Ambriz-Fernández, R.; Reyna-Fregoso, M.P.; Pizzuto-Chávez, J.; Rodríguez-Moyado, H.; Farfán-Canto, J.M.; Trueba-Christy, E.; Collazo-Jaloma, J. 1985: Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. a study of the cooperative group of hemophilia Archivos de Investigacion Medica 16(3): 225-235
Neve, R.L.; Geller, A.I. 1995: A defective herpes simplex virus vector system for gene delivery into the brain: comparison with alternative gene delivery systems and usefulness for gene therapy Clinical Neuroscience 3(5): 262-267